WO1993005065A1 - Preparation de peptides par une synthese en phase solide, et intermediaires pour la preparation - Google Patents
Preparation de peptides par une synthese en phase solide, et intermediaires pour la preparation Download PDFInfo
- Publication number
- WO1993005065A1 WO1993005065A1 PCT/GB1992/001567 GB9201567W WO9305065A1 WO 1993005065 A1 WO1993005065 A1 WO 1993005065A1 GB 9201567 W GB9201567 W GB 9201567W WO 9305065 A1 WO9305065 A1 WO 9305065A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- general formula
- group
- solid support
- amino acid
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 75
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 22
- 239000000543 intermediate Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 238000010532 solid phase synthesis reaction Methods 0.000 title abstract description 7
- -1 carboxy-protected amino Chemical class 0.000 claims abstract description 42
- 239000007787 solid Substances 0.000 claims abstract description 38
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 21
- 229920001184 polypeptide Polymers 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 47
- 229920005989 resin Polymers 0.000 claims description 45
- 239000011347 resin Substances 0.000 claims description 45
- 150000001413 amino acids Chemical class 0.000 claims description 41
- 230000008569 process Effects 0.000 claims description 32
- 125000006239 protecting group Chemical group 0.000 claims description 14
- 125000005647 linker group Chemical group 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000005370 alkoxysilyl group Chemical group 0.000 abstract description 2
- 229940024606 amino acid Drugs 0.000 description 53
- 235000001014 amino acid Nutrition 0.000 description 53
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 13
- 150000002148 esters Chemical class 0.000 description 13
- 108010022337 Leucine Enkephalin Proteins 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical compound C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 9
- 239000007790 solid phase Substances 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 241000786363 Rhampholeon spectrum Species 0.000 description 7
- 238000010647 peptide synthesis reaction Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 3
- 240000008881 Oenanthe javanica Species 0.000 description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 125000006242 amine protecting group Chemical group 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000004665 trialkylsilyl group Chemical group 0.000 description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-Leucine Natural products CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- JEIPUZRERNAIQJ-UHFFFAOYSA-N OC1=CC=CC2=C1N=NN2.C1CCCCC1N=C=NC1CCCCC1 Chemical compound OC1=CC=CC2=C1N=NN2.C1CCCCC1N=C=NC1CCCCC1 JEIPUZRERNAIQJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N acetaldehyde dimethyl acetal Natural products COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- 229940113088 dimethylacetamide Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 108091005601 modified peptides Proteins 0.000 description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- FDNAPBUWERUEDA-UHFFFAOYSA-N silicon tetrachloride Chemical compound Cl[Si](Cl)(Cl)Cl FDNAPBUWERUEDA-UHFFFAOYSA-N 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000006657 (C1-C10) hydrocarbyl group Chemical group 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- VUCNQOPCYRJCGQ-UHFFFAOYSA-N 2-[4-(hydroxymethyl)phenoxy]acetic acid Chemical compound OCC1=CC=C(OCC(O)=O)C=C1 VUCNQOPCYRJCGQ-UHFFFAOYSA-N 0.000 description 1
- OOXYJXJJWWJVLW-UHFFFAOYSA-N 2-[9-(hydroxymethyl)-9h-fluoren-2-yl]acetic acid Chemical compound C1=C(CC(O)=O)C=C2C(CO)C3=CC=CC=C3C2=C1 OOXYJXJJWWJVLW-UHFFFAOYSA-N 0.000 description 1
- OEBIVOHKFYSBPE-UHFFFAOYSA-N 4-Benzyloxybenzyl alcohol Chemical compound C1=CC(CO)=CC=C1OCC1=CC=CC=C1 OEBIVOHKFYSBPE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102400000243 Leu-enkephalin Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 229910003910 SiCl4 Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000012317 TBTU Substances 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- NOUDPBCEONUCOV-FJXQXJEOSA-N [(2s)-1-ethoxy-4-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC(C)C NOUDPBCEONUCOV-FJXQXJEOSA-N 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000001510 aspartic acids Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 238000003403 chloroformylation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- QIGLJVBIRIXQRN-ZETCQYMHSA-N ethyl (2s)-2-amino-4-methylpentanoate Chemical compound CCOC(=O)[C@@H](N)CC(C)C QIGLJVBIRIXQRN-ZETCQYMHSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 150000002307 glutamic acids Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
- 239000013034 phenoxy resin Substances 0.000 description 1
- 229920006287 phenoxy resin Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000003930 superacid Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YTZXTPSJXNNLEV-NSHDSACASA-N tris[(2-methylpropan-2-yl)oxy]silyl (2S)-2-aminopropanoate Chemical compound C[C@H](N)C(=O)O[Si](OC(C)(C)C)(OC(C)(C)C)OC(C)(C)C YTZXTPSJXNNLEV-NSHDSACASA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical compound OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/04—Esters of silicic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
- C07K1/088—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing other elements, e.g. B, Si, As
Definitions
- the present invention relates to the preparation of
- a tertiary butyl oxycarbonyl group is a typical amine protecting group, for example tert-butyl oxycarbonyl (tBoc), which may be removed either by hydrochloric acid gas in organic solvents or by using trifluoroacetic acid (TFA).
- tBoc tert-butyl oxycarbonyl
- trialkylsilyl protecting groups disclosed in this prior art document include trimethylsilyl- (TMS) and
- tert-butyldimethylsilyl- (TBDMS) esters of amino acids it is essential to employ a temporary N-protecting group, for example tBoc, to prevent N-silyl derivatisation.
- tBoc temporary N-protecting group
- the subsequent removal of the N-protection with acid yields the amino acid trialkylsilyl ester acid salt, which must be neutralised before the amino group can participate in peptide bond formation.
- the preparation of these amino acid trialkylsilyl esters is thus a three-step process.
- An example for the production of an amino acid TMS-ester is shown below: tBoc. NH . CHR. COOH + TMSC1 + Base tBoc . NH . CHR. COOTMS . + Base-HC1
- TBDMS-esters are used in solid-phase peptide synthesis.
- This activation can be difficult to achieve and an accurate measure of the amount of amino acid bound to the resin is not easy to obtain.
- this type of linkage is very stable and requires unfavourably harsh acidic conditions, such as liquid HF, for cleavage of the synthesised peptide.
- N ⁇ -amino groups is known per se in conventional synthetic chemistry (e.g. cf. CARPINO, L.A. & HAN, G.Y. (1972) J. Org. Chem 37 3404) but harsh conditions have precluded the use of such linker compounds in peptide syntheses.
- the present invention provides a process for the production of a peptide of general formula (I) (I)
- the present invention provides a process for the production of a peptide of general formula (I) (I)
- linker compounds with phosgene.
- linkers may also be attached to any solid support W bearing a terminal amino function.
- A) allows release of a newly synthesised peptide under mild conditions such as 15% piperidine in dimethyl formamide.
- B) the conditions for peptide release are slightly more rigorous, requiring 90% trifluoroacetic acid (TFA).
- Cleavage from C) can be achieved under mild basic conditions, such as 0.1N sodium hydroxide.
- the solid support W is a resin having a terminal amino group, for example commercially available resins MBHA., BHA., or aminomethyl ated resins.
- W and the linker compound are preferably reacted to form a W-Y bond in the presence of DCC/HOBt.
- linker group containing solid supports W-Y for example:
- Steps (c) or (d) and (d) or (e), respectively) can take place simultaneously.
- Any reactive side chains on residues A are protected and subsequently deprotected, as necessary by known procedures.
- the choice of side-chain protecting groups may be adjusted to suit the method of removal of the protecting group Z.
- the invention further provides compounds of general formula (II); (II)
- A is either Asp or Glu
- Figure 1 is an HPL Chromatograph of Leucine-Enkephalin synthesised using tert-butoxysilyl (TBOS) esters;
- Figure 2 is a FIB Mass Spec Analysis of Leu-Enkephalin synthesised using L-amino acid-TBOS esters;
- Figure 3 is an HPL Chromatograph of Leucine Enkephalin Alcohol
- Figure 4 is a FIB Mass Spec of Leucine Enkephalin Alcohol
- Figure 5 is a FIB Mass Spec of Leucine Enkephalin Diol.
- Figure 6 is a FIB Mass Spec of Leucine Enkephalin Chloromethyl Ketone. The invention will now be illustrated by way of example with reference to the following description.
- This compound may be produced by a process which comprises the following steps:
- a synthesis can be carried out using compound (9) according to the following procedure:
- Benzyl acetate resin Chioromethylated co-polystyrene-2% divinylbenzene (5g. 1mmol./g.) suspended in 2-methoxyethanol
- the resin was then swollen in dimethyl acetamide (2 x 10mls.) and treated with L-tryosine methyl ester hydrochloride (1.0mmol.; 0.231g.) and triethylamine (2.0mmol.; 0.112mls.) in
- the leucine-enkephalin pentapeptide was assembled by four successive cycles of addition and deprotection to yield the desired peptidyl-resin.
- a typical addition cycle consisted of treating the deprotected resin with the amino acid TBOS ester (1.0mmol.), HOBt (1.0mmol; 0.135g.) and diisoproplycarbodiimide (1.0mmol.; 0.156mls.) in DCM (10mls.) for 4 hours at room temperature. The resin would then be washed thoroughly with DCM before being deprotected by treatment with 25% TFA in DCM (10mls.) for 10 minutes at room temperature followed by washing with DCM (6 x 10mls.) before commencing the subsequent addition cycle.
- Buffer A 0.1% TFA., H 2 O
- the preferred carboxy-protected amino acids (II) are the tri-t-butoxysilyl esters. These can easily be produced in a one step process as follows:
- the reaction is rapid and typically yields 85-90% product.
- the simplicity of production contrasts favourably with the prior three step process for production of the silyl esters of W090/05738.
- the tri-t-alkoxysilyl esters, alkyl-di-t-alkoxysilyl esters and dialkyl-t-alkoxysilyl esters can be made from free amino acids without the need for N ⁇ -protection (by groups such as tBoc).
- the free amino acids are abundantly available and cheap.
- tri-t-alkoxysilyl esters, alkyl-di-t-alkoxysilyl esters and di alkyl-t-alkoxysilyl esters show good stability when stored under anhydrous conditions, hence permitting long term storage. Large scale preparation of these derivatives may be carried out well in advance of the peptide synthesis.
- esters are stable between pH 4.0 and pH 8.0 and are stable to alcoholic solvents. They can be readily removed at pH values less than 4 or greater than 8.
- the procedure for the preparation of several tri-t-butoxysilyl amino acid esters is illustrated in more detail in the example below:
- the pyridinium hydrochloride is removed by filtration, washing the precipitate with ethyl acetate (50ml). All solvents, (i.e.
- the product was characterised by means of its infra-red (I.R.) spectrum, thin layer chromatography (t.l.c.) and Mass Spectrum (M.S.).
- I.R. infra-red
- t.l.c. thin layer chromatography
- M.S. Mass Spectrum
- the mild nature of the synthetic strategy proposed may provide a means of synthesising modified peptides, such as phosphopeptides or glycopeptides, that cannot withstand the conditions used at some stages of conventional synthetic procedures.
- modified peptides such as phosphopeptides or glycopeptides
- the reversal of the direction of synthesis from the conventional C- to -N terminal also opens up the possibility of carrying out solid-phase fragment coupling for the production of large peptides.
- a further advantage of synthesising in the N to C direction is that the C-terminal remains free and this allows for modifying the C-terminal of peptides whilst they are bound on the solid support.
- Examples of C-terminal modified peptides which have been prepared are enkephalin-alcohol, -diol and -chloromethylketone. Data on these analogues is shown in Figures 3-6. The products made
- t.l.c solvent was chloroform: methanol (9:1).
- Bz refers to Benzyl.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92918056A EP0600996A1 (fr) | 1991-08-30 | 1992-08-26 | Preparation de peptides par une synthese en phase solide, et intermediaires pour la preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919118669A GB9118669D0 (en) | 1991-08-30 | 1991-08-30 | Preparation of peptides by a soliphase synthesis and intermediates therefor |
GB9118669.2 | 1991-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993005065A1 true WO1993005065A1 (fr) | 1993-03-18 |
Family
ID=10700728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1992/001567 WO1993005065A1 (fr) | 1991-08-30 | 1992-08-26 | Preparation de peptides par une synthese en phase solide, et intermediaires pour la preparation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0600996A1 (fr) |
AU (1) | AU2464992A (fr) |
GB (1) | GB9118669D0 (fr) |
WO (1) | WO1993005065A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798035A (en) * | 1996-10-03 | 1998-08-25 | Pharmacopeia, Inc. | High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay |
WO2002094857A1 (fr) * | 2001-05-23 | 2002-11-28 | The Curators Of The University Of Missouri | Synthese peptidique en phase solide inverse |
WO2006097698A1 (fr) * | 2005-03-14 | 2006-09-21 | Activotec Spp Limited | Synthese de peptide en phase solide inversee avec une etape de coiffage supplementaire |
US7786259B2 (en) | 2001-05-23 | 2010-08-31 | The Curators Of The University Of Missouri | Attachment and elaboration strategies for inverse peptide synthesis |
USRE46830E1 (en) | 2004-10-19 | 2018-05-08 | Polypeptide Laboratories Holding (Ppl) Ab | Method for solid phase peptide synthesis |
WO2019069978A1 (fr) | 2017-10-03 | 2019-04-11 | 日産化学株式会社 | Procédé de production de composé peptidique |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005738A1 (fr) * | 1988-11-19 | 1990-05-31 | Public Health Laboratory Service Board | Trialkylsilyle esters d'acides amines et leur emploi dans la synthese de peptides |
DE3924257A1 (de) * | 1989-07-19 | 1991-01-31 | Gruszecki Wojciech | Silikonester als neue schutzgruppen in der organischen chemie |
-
1991
- 1991-08-30 GB GB919118669A patent/GB9118669D0/en active Pending
-
1992
- 1992-08-26 WO PCT/GB1992/001567 patent/WO1993005065A1/fr not_active Application Discontinuation
- 1992-08-26 EP EP92918056A patent/EP0600996A1/fr not_active Withdrawn
- 1992-08-26 AU AU24649/92A patent/AU2464992A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005738A1 (fr) * | 1988-11-19 | 1990-05-31 | Public Health Laboratory Service Board | Trialkylsilyle esters d'acides amines et leur emploi dans la synthese de peptides |
DE3924257A1 (de) * | 1989-07-19 | 1991-01-31 | Gruszecki Wojciech | Silikonester als neue schutzgruppen in der organischen chemie |
Non-Patent Citations (1)
Title |
---|
CHEMICAL ABSTRACTS, vol. 115, no. 19, 11 November 1991, Columbus, Ohio, US; abstract no. 208480g, W GRUSZECKI ET AL. 'stable tri-t-butoxysilyl esters of aspartic and glutamic acid as aa new protection of their carboxyl groups' page 1076 ;column RIGHT ; * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798035A (en) * | 1996-10-03 | 1998-08-25 | Pharmacopeia, Inc. | High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay |
USRE37194E1 (en) | 1996-10-03 | 2001-05-29 | Pharmacopeia, Inc. | High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay |
WO2002094857A1 (fr) * | 2001-05-23 | 2002-11-28 | The Curators Of The University Of Missouri | Synthese peptidique en phase solide inverse |
US7214769B2 (en) | 2001-05-23 | 2007-05-08 | The Curators Of The University Of Missouri | Method for inverse solid phase synthesis of peptides |
US7786259B2 (en) | 2001-05-23 | 2010-08-31 | The Curators Of The University Of Missouri | Attachment and elaboration strategies for inverse peptide synthesis |
USRE46830E1 (en) | 2004-10-19 | 2018-05-08 | Polypeptide Laboratories Holding (Ppl) Ab | Method for solid phase peptide synthesis |
WO2006097698A1 (fr) * | 2005-03-14 | 2006-09-21 | Activotec Spp Limited | Synthese de peptide en phase solide inversee avec une etape de coiffage supplementaire |
GB2437901A (en) * | 2005-03-14 | 2007-11-07 | Activotec Spp Ltd | Inverse solid phase peptide synthesis with additional capping step |
WO2019069978A1 (fr) | 2017-10-03 | 2019-04-11 | 日産化学株式会社 | Procédé de production de composé peptidique |
CN111164092A (zh) * | 2017-10-03 | 2020-05-15 | 日产化学株式会社 | 肽化合物的制造方法 |
US20200291061A1 (en) * | 2017-10-03 | 2020-09-17 | Nissan Chemical Corporation | Method for producing peptide compound |
JPWO2019069978A1 (ja) * | 2017-10-03 | 2020-11-05 | 日産化学株式会社 | ペプチド化合物の製造方法 |
EP3693377A4 (fr) * | 2017-10-03 | 2021-06-30 | Nissan Chemical Corporation | Procédé de production de composé peptidique |
JP7196087B2 (ja) | 2017-10-03 | 2022-12-26 | 日産化学株式会社 | ペプチド化合物の製造方法 |
TWI811246B (zh) * | 2017-10-03 | 2023-08-11 | 日商日產化學股份有限公司 | 胜肽化合物之製造方法 |
CN111164092B (zh) * | 2017-10-03 | 2023-12-26 | 日产化学株式会社 | 肽化合物的制造方法 |
Also Published As
Publication number | Publication date |
---|---|
EP0600996A1 (fr) | 1994-06-15 |
AU2464992A (en) | 1993-04-05 |
GB9118669D0 (en) | 1991-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2875834B2 (ja) | ウレタン保護アミノ酸‐n‐カルボキシ無水物 | |
JP2513775B2 (ja) | 固相ペプチド合成用支持体 | |
US4515920A (en) | Synthesis of peptides and proteins | |
CA1231333A (fr) | Synthese rapide de quantites de peptides a l'aide de melanges d'anhydrides | |
JP2003055396A (ja) | ペプチドの高速溶液合成方法 | |
KR20230112694A (ko) | 화학적 합성을 위한 조성물 및 방법 | |
JPS60164495A (ja) | N‐ホルミルアミノ酸とペプチド残基の酵素的結合法 | |
WO1993005065A1 (fr) | Preparation de peptides par une synthese en phase solide, et intermediaires pour la preparation | |
US5306562A (en) | Xanthenylamide handle for use in peptide synthesis | |
US5712367A (en) | Process for the solubilization of peptides and process for peptide synthesis | |
US5994588A (en) | Peptide purification method using novel linker and solid-phase ligand | |
KR100203548B1 (ko) | 고체상 합성에 의한 펩티드의 제조방법 | |
CZ289747B6 (cs) | Nalfa-2-(4-Nitrofenylsulfonyl)ethoxykarbonyl-aminokyseliny, způsob jejich přípravy a jejich pouľití | |
JPH04502908A (ja) | アミノ酸のトリアルキルシリルエステルおよびペプチド合成におけるその使用 | |
CA1315470C (fr) | Systemes a phase solide contenant une chaine laterale alkylique, procedes pour leur preparation et leur utilisation dans des reactions en phase solide | |
US5324786A (en) | Process for preparation of a solid phase system | |
KR101889893B1 (ko) | 선별적 용해도를 갖는 트리페닐메탄 유도체 및 그의 용도 | |
de la Torre et al. | Solid-phase peptide synthesis using N α-trityl-amino acids | |
EP0277561B1 (fr) | Dérivé de l'arginine, procédé pour sa préparation et son utilisation dans la synthèse de peptides | |
US6750312B1 (en) | Process for the preparation of supports for solid phase synthesis | |
US20070111930A1 (en) | Process for preparing vapreotide | |
JPH04221394A (ja) | ペプチド脂質 | |
RU2777327C1 (ru) | Способ синтеза пептидов | |
JP2748897B2 (ja) | 新規なアルギニン誘導体およびこれを用いるペプチドの製造方法 | |
AU626608B2 (en) | A process for the preparation of tripeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992918056 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992918056 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1994 199156 Date of ref document: 19940623 Kind code of ref document: A Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992918056 Country of ref document: EP |